MK-677 Sleep Architecture: Research Applications Comparison
Cognitive performance studies REM sleep increase of 20–50% enhances memory consolidation and learning retention measured via next-day recall tasks GH-mediated cholinergic pathway modulation shortens REM latency and extends REM duration 25mg administered 60–90
This comparison does not assign a generated winner or score.
- Cognitive performance studies
- REM sleep increase of 20–50% enhances memory consolidation and learning retention measured via next-day recall tasks
- GH-mediated cholinergic pathway modulation shortens REM latency and extends REM duration
- 25mg administered 60–90 minutes pre-sleep
- Most reproducible cognitive benefit tied to REM enhancement; effects measurable within 3–5 days
- Age-related sleep decline research
- Slow-wave sleep restoration to levels comparable to middle-aged adults, reversing 70–80% of age-related decline
- Amplifies nocturnal GH pulse frequency and amplitude, directly increasing stage 3–4 sleep duration
- 25mg daily, evening administration
- Strongest evidence base in elderly populations; no tolerance observed across 12-month trials
- Metabolic recovery protocols
- Stage 4 deep sleep extension by 50+ minutes per night drives cellular repair, immune function, and anabolic processes
- GH surge during slow-wave sleep promotes protein synthesis, tissue repair, and metabolic restoration
- 12.5–25mg pre-sleep in conjunction with resistance training schedules
- Sleep architecture changes correlate with improved recovery markers (reduced cortisol, elevated IGF-1)
- Sleep fragmentation studies
- Reduces wake-after-sleep-onset events and increases sleep efficiency from baseline 75–80% to 85–90%
- Stabilizes sleep cycles through sustained GH elevation, reducing cortisol-driven mid-cycle awakenings
- 25mg nightly for minimum 7–14 days to observe consolidation effects
- Objective polysomnography data shows consistent reduction in sleep interruptions; subjective 'restfulness' aligns